| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
TLPH
Talphera
|
Apr 30, 2026 | BUY |
Buy
+340.4% avg upside
15 analysts
|
$3.00
180.35% Upside
|
-1.1% |
|
MTVA
MetaVia
|
Sep 17, 2025 | BUY |
Strong Buy
+1920.9% avg upside
13 analysts
|
$132.00
8818.89% Upside
|
-87.2% |
|
UNCY
Unicycive Therapeutics
|
Apr 11, 2025 | BUY |
Strong Buy
+828.5% avg upside
10 analysts
|
$75.00
1208.96% Upside
|
+21.0% |
|
ARCT
Arcturus Therapeutics
|
Apr 11, 2025 | BUY |
Buy
+303.6% avg upside
36 analysts
|
$60.00
724.08% Upside
|
-13.8% |
|
AKBA
Akebia Therapeutics
|
Apr 04, 2025 | BUY |
Strong Buy
+695.6% avg upside
16 analysts
|
$7.50
504.83% Upside
|
-22.0% |
|
IVA
Inventiva
|
Apr 03, 2025 | BUY |
Strong Buy
+310.9% avg upside
16 analysts
|
$13.00
232.49% Upside
|
-57.4% |
|
GALT
Galectin Therapeutics
|
Apr 02, 2025 | HOLD |
Strong Buy
+116.2% avg upside
8 analysts
|
— | +102.3% |
|
ALGS
Aligos Therapeutics
|
Mar 31, 2025 | BUY |
Strong Buy
+724.6% avg upside
11 analysts
|
$70.00
1152.24% Upside
|
-9.9% |
|
ASMB
Assembly Biosciences
|
Mar 21, 2025 | HOLD |
Strong Buy
+22.1% avg upside
10 analysts
|
— | +158.5% |
|
ACXP
Acurx Pharmaceuticals
|
Mar 20, 2025 | BUY |
Strong Buy
+4446.9% avg upside
4 analysts
|
$240.00
14900.10% Upside
|
-33.2% |
|
PLRX
Pliant Therapeutics
|
Mar 18, 2025 | HOLD |
Buy
+1804.7% avg upside
21 analysts
|
— | -24.3% |
|
SGMT
Sagimet Biosciences, Inc. Class A
|
Mar 11, 2025 | BUY |
Strong Buy
+270.5% avg upside
15 analysts
|
$32.00
320.47% Upside
|
+69.3% |
|
MIRM
Mirum Pharmaceuticals
|
Feb 27, 2025 | BUY |
Strong Buy
-6.9% avg upside
21 analysts
|
$72.00
42.75% Downside
|
+96.5% |
|
MDGL
Madrigal Pharmaceuticals
|
Feb 27, 2025 | BUY |
Strong Buy
-9.8% avg upside
31 analysts
|
$405.00
23.28% Downside
|
+28.7% |
|
ARDX
Ardelyx
|
Feb 20, 2025 | HOLD |
Strong Buy
+157.2% avg upside
21 analysts
|
$5.50
4.45% Upside
|
+0.2% |
|
RARE
Ultragenyx Pharmaceutical
|
Feb 18, 2025 | BUY |
Strong Buy
+98.5% avg upside
36 analysts
|
$95.00
183.88% Upside
|
-53.1% |
|
ENTA
Enanta Pharmaceuticals
|
Feb 10, 2025 | BUY |
Buy
+117.2% avg upside
17 analysts
|
$18.00
19.21% Upside
|
+188.4% |
|
ABUS
Arbutus Biopharma
|
Jan 21, 2025 | BUY |
Strong Buy
+81.4% avg upside
15 analysts
|
$5.00
2.77% Upside
|
+29.0% |
|
NAMS
NewAmsterdam Pharma Company
|
Jan 14, 2025 | BUY |
Strong Buy
+34.7% avg upside
18 analysts
|
$48.00
37.81% Upside
|
+34.8% |
|
TVTX
Travere Therapeutics
|
Jan 14, 2025 | BUY |
Strong Buy
-17.2% avg upside
22 analysts
|
$22.00
61.38% Downside
|
+69.5% |
|
ITRMF
Iterum Therapeutics
|
Sep 10, 2024 | BUY |
Buy
+14262.0% avg upside
5 analysts
|
$5.00
9919.98% Upside
|
· |
|
AUPH
Aurinia Pharmaceuticals
|
Sep 05, 2024 | BUY |
Strong Buy
-2.1% avg upside
12 analysts
|
$13.00
16.71% Downside
|
+79.5% |
|
SYBX
Synlogic
|
Apr 24, 2024 | HOLD |
Buy
+3333.9% avg upside
11 analysts
|
— | -38.0% |
|
ZVSA
ZyVersa Therapeutics
|
Mar 26, 2024 | BUY |
Buy
+84051.5% avg upside
2 analysts
|
$120.00
84051.48% Upside
|
· |
|
VERA
Vera Therapeutics
|
Jan 25, 2024 | BUY |
Strong Buy
+62.6% avg upside
19 analysts
|
$25.00
39.24% Downside
|
+34.0% |
|
NBRVF
Nabriva Therapeutics
|
Mar 27, 2023 | HOLD |
Strong Buy
+13374900.0% avg upside
9 analysts
|
— | · |
|
GLMD
Galmed Pharmaceuticals
|
Mar 27, 2023 | HOLD |
Buy
+4184.3% avg upside
13 analysts
|
— | -94.5% |
|
SMMT
Summit Therapeutics
|
Dec 21, 2021 | HOLD |
Strong Buy
+89.6% avg upside
27 analysts
|
— | +60.4% |
|
ATXI
Avenue Therapeutics
|
Nov 29, 2021 | HOLD |
Strong Buy
+5801.6% avg upside
4 analysts
|
— | · |
|
FR:GNFT
Genfit
|
May 12, 2020 | HOLD |
Strong Buy
+131.8% avg upside
5 analysts
|
— | · |
|
FR:IVA
Inventiva
|
Mar 18, 2020 | BUY |
Strong Buy
+418.7% avg upside
5 analysts
|
$12.00
250.88% Upside
|
· |
|
COLL
Collegium Pharmaceutical
|
Feb 07, 2020 | BUY |
Strong Buy
+13.8% avg upside
8 analysts
|
$31.00
16.31% Downside
|
-4.8% |
|
VIVS
VivoSim Labs
|
Nov 11, 2019 | HOLD |
Buy
+193.3% avg upside
5 analysts
|
— | +23.3% |
|
SPRO
Spero Therapeutics
|
Aug 12, 2019 | BUY |
Buy
+523.4% avg upside
12 analysts
|
$27.00
1127.18% Upside
|
+36.3% |
|
TRVN
Trevena
|
Mar 14, 2019 | HOLD |
Buy
+949900.0% avg upside
11 analysts
|
$1.25
83233.35% Upside
|
· |
|
VKTX
Viking Therapeutics
|
Nov 28, 2017 | BUY |
Strong Buy
+92.1% avg upside
31 analysts
|
$7.00
81.33% Downside
|
+304.3% |
|
VXRT
Vaxart
|
Nov 06, 2017 | HOLD |
Strong Buy
+1118.8% avg upside
8 analysts
|
— | -53.2% |
|
NEPTF
Neptune Wellness Solutions
|
Jan 30, 2015 | BUY |
Strong Buy
+400434400.1% avg upside
7 analysts
|
$5.00
499999900.01% Upside
|
· |
|
BCRX
BioCryst
|
Jan 26, 2015 | BUY |
Strong Buy
+87.4% avg upside
24 analysts
|
$20.00
103.16% Upside
|
-35.7% |
|
ACUR
Acura Pharmaceuticals
|
Jan 09, 2015 | BUY |
Buy
+333233.3% avg upside
2 analysts
|
$5.00
555455.61% Upside
|
· |
|
XOMA
XOMA Royalty Corporation
|
Nov 14, 2014 | BUY |
Buy
-47.9% avg upside
11 analysts
|
$9.00
79.15% Downside
|
-65.3% |
|
AFFY
Affymax
|
Mar 19, 2013 | SELL |
Hold
+942207.6% avg upside
3 analysts
|
$0.50
38361.44% Upside
|
+17.9% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.